Lyft, Inc. expands its Grocery Access Program across 15 U.S. cities

Through the latest move, Lyft aims to mitigate transportation barriers to healthy food. Lyft Inc., a San Francisco-based transportation network company, has made it to the headlines for planning to offer discounted rides at $2.50 to groce....

Venmo boasts of 40 million users, claims parent company PayPal

The leading American operator of online payments, PayPal, has reportedly disclosed that its subsidiary mobile payments service platform, Venmo, currently holds a user base of around 40 million. The US-based company has revealed this metric....

Oxurion & Bicycle Therapeutics declare full enrollment for DME study

Bicycle Therapeutics, a biotech firm pioneering a new therapeutic class based on its patented bicyclic peptide or Bicycle® platform, and Oxurion have recently declared complete registration of Oxurion’s Phase I clinical trial plan....

Facebook might expect a $5 billion FTC fine over privacy scandal

The company anticipates a fine between $3 billion to $5 billion in association with an ongoing inquiry by the FTC. Social media giant, Facebook, Inc. is reportedly bracing for a huge fine from federal regulators as the company recently ann....

Samsung plans to develop its own blockchain network based on Ethereum

When the development of the blockchain is completed then Samsung may also introduce a Samsung Coin token Samsung, the South Korean electronics giant is reportedly in the works to develop its own blockchain network which could lead to the i....

CIA alleges Huawei of being funded by the Chinese state security

The US Intelligence service, Central Intelligence Agency, has grabbed the headlines for publicly accusing the Chinese multinational consumer electronics company, Huawei Technologies, of being funded by China’s National Security Commis....

Precision BioSciences doses first patient in CAR T cell therapy trial

Precision is creating PBCAR0191 in partnership with Servier, a multinational pharmaceutical firm   The company believes that the patient dosed in the trial is also the first US-based clinical trial to assess an allogeneic CAR T cel....

BioTime to present OpRegen® Phase I/IIa study outcomes at ARVO 2019

BioTime Incorporation, a clinical stage biotechnology firm developing newfangled cellular treatments, has recently declared that updated outcomes from a Phase I/IIa clinical study of OpRegen®, its chief product candidate, would be prese....

French business tycoons commit €600m to restore Notre Dame Cathedral

Pledges for donation came after firefighters confirmed that the fire had been extinguished completely   President Emmanuel Macron plans to begin a national fundraising campaign for the cathedral’s reconstruction Major corpo....

FDA approves Gelesis  prescription weight-loss drug Plenity for adults

Plenity is has been cleared for obese or overweight adults having a body mass index of at least 25 Reports confirm that the U.S. Food and Drug Administration (FDA) has recently granted approval to an innovative prescription drug aimed at h....